Arrowhead Pharmaceuticals Inc Faces Financial Challenges but Remains Committed to Product Pipeline
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) unveiled its fiscal 2024 first-quarter financial results, concluding on December 31, 2023, which fell short ...